SCHEMBL5111554

SCHEMBL5111554

Cc1cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c(F)c(NC(=O)C(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.38
THRB P10828 1/20 0.38
ALDH1A1 P00352 5/20 0.37
HPGD P15428 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
RAB9A P51151 2/20 0.37
LMNA P02545 2/20 0.37
ABL1 P00519 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
RIN1 Q13671 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MDM2 Q00987 1/20 0.35
TOP2A P11388 1/20 0.35
HTT P42858 2/20 0.35
MAPK1 P28482 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722767 0.95 THRA (0.47) THRATHRBALDH1A1HPGDMEN1
SCHEMBL5119943 0.91 ALDH1A1 (0.38) THRATHRBALDH1A1HPGDMEN1
SCHEMBL4931300 0.91 ALDH1A1 (0.37) ALDH1A1HPGDMEN1KMT2ARAB9A
SCHEMBL5109654 0.90 THRA (0.38) THRATHRBALDH1A1HPGDMEN1
SCHEMBL5107711 0.90 ALDH1A1 (0.39) ALDH1A1HPGDMEN1KMT2ARAB9A
SCHEMBL5116899 0.89 ALDH1A1 (0.39) THRATHRBALDH1A1HPGDMEN1
SCHEMBL4933336 0.88 ALDH1A1 (0.38) THRBALDH1A1HPGDMEN1KMT2A
SCHEMBL4935198 0.87 ALDH1A1 (0.38) THRBALDH1A1HPGDMEN1KMT2A
SCHEMBL5722776 0.87 THRB (0.38) THRATHRBALDH1A1HPGDMEN1
SCHEMBL5104586 0.86 HPGD (0.44) THRATHRBALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRA 3/4885THRB 4/4885ALDH1A1 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.